Nav: Home

Pancreatic cancer: Mutable cancer cells are more dangerous

July 09, 2018

Pancreatic cancer often spreads, forming metastases in the liver or lungs. The prognosis is better for patients with metastases in the lungs. However, the organ that is more likely to be affected depends on the cancer cells' ability to alter their characteristics and shape - as a research team at the Technical University of Munich (TUM) has discovered.

Cells in a tissue or tumor establish contacts with other cells and assume a scale-like appearance. Cancer cells that form metastases, however, must first alter their shape and characteristics. They have to modify their metabolism and detach themselves from the cluster of cells making up the tumor. As a result, they become long and thin, which allows them to enter nearby blood vessels. They then use the bloodstream as a transport route to reach other organs and proliferate in tissue there.

The cells must then transform themselves once again. They have to re-establish contacts with other cells in order to cling to them, so to speak. Not all cancer cells possess this flexibility, technically known as plasticity. Dr Maximilian Reichert, lead author of the new study and research group leader in the Internal Medicine Unit II of TUM university hospital Klinikum rechts der Isar, discovered why this is the case and what consequences it has for the spread of pancreatic cancer. The findings were published in the journal Developmental Cell.

Liver or lungs - what is the decisive factor?

"We were able to show that the spread of pancreatic cancer to the liver depends on the plasticity of the cancer cells. If the cells are unable to establish cell-to-cell contacts, they are passively flushed into the lungs by the bloodstream, where they become lodged," Reichert explains. "This course of the disease is more favorable for patients, because lung tumors are easier to control."

The plasticity of a cancer cell depends crucially on the presence of a cell adhesion molecule: the protein E-cadherin. Located on the cell surface, it is responsible for cell-to-cell contacts. Using a mouse model, the research team discovered that the absence of E-cadherin results in pancreatic cancer cells spreading to the lungs but not to the liver.

When the protein was present and functional, the cancer cells were also able to invade the liver. The researchers believe that this is because the cancer cells are able to take hold in liver tissue and to colonize the organ due to close cell-to-cell contacts established with the help of E-cadherin. By altering the presence of E-cadherin, the research team was able to control the metastasis process in mice.

Epigenetic factors as cause

The research team discovered that these mechanisms are evidently controlled in the tumor by epigenetic programs. In the process, the genetic material (DNA) itself is not altered. Instead, chemical factors determine how strongly or weakly a section of DNA is read.

Together with colleagues at Klinikum rechts der Isar, the team led by Maximilian Reichert plans to investigate whether these epigenetic programs can be inhibited or are suitable targets for treatment. "The more we understand about the formation of metastases, the better we'll be able to influence the process. This is particularly important in the case of pancreatic cancer, because nearly all pancreatic cancer patients die as a result of metastases," as Reichert states.
-end-
Publication:

Maximilian Reichert, Basil Bakir, Leticia Moreira, Jason R. Pitarresi, Karin Feldmann, Lauren Simon, Kensuke Suzuki, Ravikanth Maddipati, Andrew D. Rhim, Anna M. Schlitter, Mark Kriegsmann, Wilko Weichert, Matthias Wirth, Kathleen Schuck, Günter Schneider, Dieter Saur, Albert B. Reynolds, Andres J. Klein-Szanto, Burcin Pehlivanoglu, Bahar Memis, N. Volkan Adsay, Anil K. Rustgi, Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer, Developmental Cell Vol. 45 Iss. 6, June 18, 2018, DOI: 10.1016/j.devcel.2018.05.025
https://www.cell.com/developmental-cell/fulltext/S1534-5807(18)30418-0

Contact:

Dr. med. Maximilian Reichert
Clinic and Polyclinic for Internal Medicine II
Klinikum rechts der Isar of TUM
Tel.: +49 (0)?89 41?40?-?27?45
maximilian.reichert@mri.tum.de

More Information:

Dr. Maximilian Reichert heads a Max Eder junior research group and is a member of the Modeling and Targeting of Pancreatic Cancer special research division (SFB1321, spokesperson: Professor Roland M. Schmid), which investigates, among other things, the clinical use of plasticity as a therapeutic target structure.

Profile of Maximilian Reichert

https://www.professoren.tum.de/en/tum-junior-fellows/r/reichert-maximilian/

Research Group of Maximilian Reichert

https://www.med2.mri.tum.de/en/research/ag-reichert.php

Clinic and Polyclinic for Internal Medicine II at TUM Klinikum rechts der Isar

https://www.med2.mri.tum.de/en/index.php

Technical University of Munich (TUM)

Related Cancer Cells Articles:

Cancer cells send signals boosting survival and drug resistance in other cancer cells
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Single gene encourages growth of intestinal stem cells, supporting 'niche' cells -- and cancer
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Prostate cancer cells grow with malfunction of cholesterol control in cells
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Immune therapy scientists discover distinct cells that block cancer-fighting immune cells
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
New system developed that can switch on immune cells to attack cancer cells
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Sleep hormone helps breast cancer drug kill more cancer cells
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.

Related Cancer Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...